ProGnosis Biotech participated as an exhibitor at the 15th World Mycotoxin Forum (WMF) 2025, held from April 7–9 in Salzburg, Austria. As one of the leading global events dedicated to mycotoxin management, WMF 2025 provided a unique platform for the company to highlight its latest advancements in rapid testing technologies and mobile app integration for the food and feed industries.
Throughout the conference, ProGnosis Biotech engaged with global stakeholders to demonstrate how its mycotoxin detection tools accelerate decision-making and support safer, more transparent supply chains. The company contributed to the scientific program with two research poster presentations:
- The first introduced Quantum Ochratoxin Green, a lateral flow test developed for rapid ochratoxin detection in grains, cereals, and nuts.
- The second featured a high-sensitivity ELISA method for aflatoxin B1 detection in human serum, highlighting the company’s expanding research into clinical food safety applications.
In addition to technical contributions, ProGnosis Biotech also delivered a company presentation underscoring the role of speed, accuracy and digital connectivity in modern mycotoxin control—reinforcing the value of real-time data for public health and regulatory compliance.
Participation in WMF 2025 aligns with the company’s continued mission to advance innovative, field-ready diagnostics backed by scientific rigor and international trust. The company extends its appreciation to the organizers and participants of WMF 2025 and looks forward to building on the insights gained to further elevate global mycotoxin risk management.
